Northern Trust Corp Sarepta Therapeutics, Inc. Transaction History

Northern Trust Corp

  • $761 Billion
  • Q3 2025

A detailed history of Northern Trust Corp transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 638,780 shares of SRPT stock, worth $12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
638,780
Previous 759,553 15.9%
Holding current value
$12 Million
Previous $13 Million 5.23%
% of portfolio
0.0%
Previous 0.0%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$11.93 - $21.97 $1.44 Million - $2.65 Million
-120,773 Reduced 15.9%
638,780 $12.3 Million
Q2 2025

Aug 13, 2025
SELL
$17.1 - $63.66 $175,514 - $653,406
-10,264 Reduced 1.33%
759,553 $13 Million
Q1 2025

May 13, 2025
SELL
$63.82 - $127.89 $2.15 Million - $4.31 Million
-33,694 Reduced 4.19%
769,817 $49.1 Million
Q4 2024

Feb 14, 2025
BUY
$104.54 - $137.94 $15.5 Million - $20.4 Million
147,874 Added 22.55%
803,511 $97.7 Million
Q3 2024

Nov 13, 2024
SELL
$124.33 - $156.75 $1.55 Million - $1.95 Million
-12,441 Reduced 1.86%
655,637 $81.9 Million
Q2 2024

Aug 14, 2024
BUY
$113.33 - $163.85 $26.9 Million - $38.9 Million
237,255 Added 55.07%
668,078 $106 Million
Q1 2024

May 14, 2024
SELL
$93.7 - $141.53 $631,819 - $954,336
-6,743 Reduced 1.54%
430,823 $55.8 Million
Q4 2023

Feb 13, 2024
BUY
$67.31 - $124.76 $817,345 - $1.51 Million
12,143 Added 2.85%
437,566 $42.2 Million
Q3 2023

Nov 13, 2023
BUY
$102.5 - $123.59 $1.52 Million - $1.84 Million
14,868 Added 3.62%
425,423 $51.6 Million
Q2 2023

Aug 11, 2023
BUY
$106.4 - $157.19 $1.08 Million - $1.59 Million
10,136 Added 2.53%
410,555 $47 Million
Q1 2023

May 15, 2023
BUY
$117.53 - $155.99 $1.03 Million - $1.37 Million
8,793 Added 2.25%
400,419 $55.2 Million
Q4 2022

Feb 13, 2023
BUY
$100.86 - $132.13 $612,522 - $802,425
6,073 Added 1.58%
391,626 $50.7 Million
Q3 2022

Nov 14, 2022
BUY
$75.71 - $119.24 $191,243 - $301,200
2,526 Added 0.66%
385,553 $42.6 Million
Q2 2022

Aug 12, 2022
SELL
$62.69 - $88.44 $1.1 Million - $1.56 Million
-17,599 Reduced 4.39%
383,027 $28.7 Million
Q1 2022

May 13, 2022
SELL
$63.15 - $90.42 $350,166 - $501,378
-5,545 Reduced 1.37%
400,626 $31.3 Million
Q4 2021

Feb 08, 2022
BUY
$77.28 - $99.42 $1.06 Million - $1.37 Million
13,744 Added 3.5%
406,171 $36.6 Million
Q3 2021

Nov 15, 2021
BUY
$65.97 - $92.48 $278,195 - $389,988
4,217 Added 1.09%
392,427 $36.3 Million
Q2 2021

Aug 13, 2021
SELL
$69.38 - $86.75 $6.56 Million - $8.21 Million
-94,592 Reduced 19.59%
388,210 $30.2 Million
Q1 2021

May 12, 2021
SELL
$72.25 - $168.95 $577,638 - $1.35 Million
-7,995 Reduced 1.63%
482,802 $36 Million
Q4 2020

Feb 11, 2021
BUY
$125.56 - $178.74 $335,496 - $477,593
2,672 Added 0.55%
490,797 $83.7 Million
Q3 2020

Nov 16, 2020
BUY
$127.12 - $172.34 $1.4 Million - $1.89 Million
10,982 Added 2.3%
488,125 $68.5 Million
Q2 2020

Aug 14, 2020
BUY
$93.0 - $171.7 $1.52 Million - $2.8 Million
16,316 Added 3.54%
477,143 $76.5 Million
Q1 2020

May 14, 2020
BUY
$82.38 - $131.64 $1.85 Million - $2.96 Million
22,486 Added 5.13%
460,827 $45.1 Million
Q4 2019

Feb 14, 2020
BUY
$76.53 - $135.58 $199,437 - $353,321
2,606 Added 0.6%
438,341 $56.6 Million
Q3 2019

Nov 13, 2019
BUY
$72.81 - $156.91 $7.29 Million - $15.7 Million
100,157 Added 29.85%
435,735 $32.8 Million
Q2 2019

Aug 13, 2019
BUY
$112.21 - $151.95 $2.57 Million - $3.48 Million
22,903 Added 7.32%
335,578 $51 Million
Q1 2019

May 13, 2019
SELL
$106.67 - $151.68 $598,632 - $851,228
-5,612 Reduced 1.76%
312,675 $37.3 Million
Q4 2018

Feb 12, 2019
BUY
$97.32 - $148.76 $1.9 Million - $2.9 Million
19,473 Added 6.52%
318,287 $34.7 Million
Q3 2018

Nov 14, 2018
BUY
$115.31 - $161.51 $72,299 - $101,266
627 Added 0.21%
298,814 $48.3 Million
Q2 2018

Sep 18, 2018
SELL
$71.74 - $153.69 $289,614 - $620,446
-4,037 Reduced 1.34%
298,187 $39.4 Million
Q2 2018

Aug 14, 2018
SELL
$71.74 - $153.69 $29.5 Million - $63.2 Million
-411,535 Reduced 57.66%
302,224 $39.9 Million
Q1 2018

May 09, 2018
SELL
$54.02 - $82.27 $22,310 - $33,977
-413 Reduced 0.06%
713,759 $52.9 Million
Q4 2017

Feb 14, 2018
BUY
$47.64 - $56.75 $168,169 - $200,327
3,530 Added 0.5%
714,172 $39.7 Million
Q3 2017

Nov 13, 2017
BUY
$35.73 - $47.15 $25.4 Million - $33.5 Million
710,642
710,642 $32.2 Million

Others Institutions Holding SRPT

# of Institutions
406
Shares Held
83.7M
Call Options Held
5.27M
Put Options Held
5.94M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $1.65B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email